Tyrosine Derived

Tyrosine-derived compounds are biologically active molecules synthesized from the amino acid tyrosine, a precursor whose products regulate signaling, pigmentation, and metabolism. Enzyme-catalyzed reactions modify tyrosine through hydroxylation, decarboxylation, oxidation, or iodination; for example, tyrosine hydroxylase produces L-DOPA, which is converted to dopamine and then to norepinephrine and epinephrine, while other pathways generate melanin and thyroid hormones. These compounds are central to nervous-system communication, endocrine regulation, and protection from ultraviolet radiation. Studying their biosynthesis helps explain physiological function and provides a foundation for investigating disorders involving neurotransmitter balance, thyroid activity, and pigment production.

Tyrosine Derived - Related Videos

Education

JoVE Core - Cell Biology

Receptor Tyrosine Kinases

0 Views •

2025

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...

Research

JoVE Journal - Medicine

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

0 Views •

Cited by 6 •

2013

Receptor tyrosine kinases are ectopically expressed in many cancers and have been identified as therapeutic targets in acute leukemia. This manuscript describes an efficient strategy for pre-clinical evaluation of tyrosine kinase inhibitors for the treatment of acute leukemia.

Development and Application of Rapamycin-regulated Tyrosine Phosphatases

0 Views •

2024

This protocol describes the design, creation, and application of rapamycin-regulated phosphatases. This method provides high specificity and tight temporal control of phosphatase activation in living cells.

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

0 Views •

Cited by 1 •

2018

Here, we present a protocol for antibody arrays to identify alterations in signaling pathways in various cellular models. These changes, caused by drugs/hypoxia/ultra-violet light/radiation, or by overexpression/downregulation/knockouts, are important for various disease models and can indicate whether a therapy will be effective or can identify mechanisms of drugs resistance.

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

0 Views •

2024

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath. TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

View All Results

FAQs

Related Topics